Most Recent

image: Discovering Novel Antibiotics

Discovering Novel Antibiotics

By | February 1, 2017

Three methods identify and activate silent bacterial gene clusters to uncover new drugs

0 Comments

image: How to Build Bioinformatic Pipelines Using Galaxy

How to Build Bioinformatic Pipelines Using Galaxy

By | August 1, 2016

A point-and-click interface alternative to command-line tools that allows researchers to easily create, run, and troubleshoot serial sequence analyses

0 Comments

image: Messages in the Noise

Messages in the Noise

By | August 1, 2015

After spending more than a decade developing tools to study patterns in gene sequences, bioinformaticians are now working on programs to analyze epigenomics data.

0 Comments

image: Getting Your Sugar Fix

Getting Your Sugar Fix

By | April 1, 2015

A guide to glycan microarrays

1 Comment

image: Nuclear Cartography

Nuclear Cartography

By | October 1, 2014

Techniques for mapping chromosome conformation

0 Comments

image: Entry Requirements

Entry Requirements

By | September 1, 2014

Recent developments in cell transfection and molecular delivery technologies

0 Comments

image: Hear Ye, Hear Ye

Hear Ye, Hear Ye

By | May 1, 2014

Tools for tracking quorum-sensing signals in bacterial colonies

2 Comments

image: Gene Silencing Is Golden

Gene Silencing Is Golden

By | August 1, 2013

A beginner’s how-to on RNAi screening in mammalian cells

0 Comments

image: Buying Cell-Culture Products

Buying Cell-Culture Products

By | March 1, 2013

A survey of The Scientist readers reveals who buys cell-growth products from whom, and why.

0 Comments

image: Set It and Forget It

Set It and Forget It

By | March 1, 2013

A tour of three systems for automating cell culture

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham